## CRDO: Credo Technology Group Holding  - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.10 indicates fundamental undervaluation. Quality metrics strong (ROE 23%, ROA 12%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-8.4% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($148.56)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Credo Technology Group Holding Ltd. (CRDO) is a Great Momentum Stock: Should You Buy?**
- Source: Nasdaq | 20251208T171044 | Bullish | Relevance: 99%
-  Credo Technology Group Holding Ltd. (CRDO) is identified as a strong momentum stock with a Zacks Momentum Style Score of A and a Zacks Rank of #1 (Strong Buy). The article highlights CRDO's impressive price performance over various periods, outperforming both its industry and the S&P 500. Positive earnings estimate revisions further support its strong outlook, suggesting potential for continued growth.

**2. Analysts Offer Insights on Technology Companies: Credo Technology Group Holding Ltd (CRDO) and Science Applications (SAIC)**
- Source: The Globe and Mail | 20251206T040103 | Bullish | Relevance: 98%
-  This article provides analyst insights on two technology companies: Credo Technology Group Holding Ltd (CRDO) and Science Applications (SAIC). Craig-Hallum analyst Richard Shannon maintained a Buy rating on CRDO, emphasizing a Strong Buy consensus among analysts with an average price target of $223.89. For SAIC, William Blair analyst Louie DiPalma reiterated a Hold rating, aligning with a general Hold consensus on the Street with an average price target of $110.67.

**3. Credo's Licensing Pact With Siemon Highlights Push Into Scalable Data-Center Connectivity**
- Source: Finviz | 20251208T110800 | Bullish | Relevance: 98%
- Credo Technology Group Holding Ltd. (NASDAQ:CRDO) has announced a license agreement with The Siemon Company for Credo's active electrical cable (AEC) technology patents, with terms remaining confidential. This partnership aligns with Credo's strategy to address bandwidth bottlenecks and improve energy efficiency in AI-driven networks, specifically targeting scalable and power-aware connectivity solutions. The agreement underscores Credo's commitment to advancing high-speed Ethernet port speeds crucial for AI, cloud, and hyperscale networks.

**4. Credo Technology Group Holding (CRDO) Price Target Increased by 30.90% to 219.11**
- Source: Nasdaq | 20251206T071012 | Bullish | Relevance: 98%
- Credo Technology Group Holding (CRDO) has seen its average one-year price target increase by 30.90% to $219.11 per share. This updated target is based on an average of analyst estimates, ranging from $136.35 to $262.50 per share, and represents a 24.47% increase from the last closing price. Institutional ownership in CRDO has also risen, with several large funds increasing their holdings, indicating a bullish sentiment.

**5. Why Credo Technology Group (CRDO) Might be Well Poised for a Surge**
- Source: Your Wyoming Link | 20251206T040103 | Bullish | Relevance: 98%
-  Credo Technology Group (CRDO) is showing strong potential for a stock surge due to significant upward revisions in its earnings estimates by analysts. The company currently holds a Zacks Rank #1 (Strong Buy), indicating strong agreement among analysts regarding its improving earnings prospects for both the current quarter and the full year. This positive trend in earnings estimate revisions typically correlates with near-term stock price movements, making CRDO a potentially solid addition to investment portfolios.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Roth Capital | $250 | $170 | +47% |
| 2025-12-02 | Mizuho | $225 | $165 | +36% |
| 2025-12-02 | B of A Securiti | $240 | $165 | +45% |
| 2025-12-02 | Barclays | $220 | $165 | +33% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Roth Capital | main | Buy |
| 2025-12-02 | Mizuho | main | Outperform |
| 2025-12-02 | B of A Securiti | main | Buy |
| 2025-12-02 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.00M) |
| Sells | 30 ($25.86M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Blackrock Inc.: 9.7% (+18.1%)
- Vanguard Group Inc: 9.2% (+0.9%)
- JPMORGAN CHASE & CO: 8.5% (+136.6%)
- Price (T.Rowe) Assoc: 3.0% (+563.8%)
- Point72 Asset Manage: 2.6% (+15.3%)

### Key Risks

1. High beta (2.63) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Heavy insider selling: $26M sold (30 transactions in 90 days).
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Analyst target momentum: 5 raises (avg +36%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.10 indicates undervaluation relative to growth. Quality metrics strong (ROE 23%, ROA 12%, margin 27%). Balance sheet: strong liquidity (8.9x), low leverage (D/E 0.13). Revenue growth strong at 37% YoY. Analyst sentiment positive (5 raises, avg +36%). Insider selling cluster ($25.9M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.3B |
| Beta | 2.63 |
| 52W Range | $29.09 - $213.80 |
| Short Interest | 5.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.10 |
| Forward P/E | 49.2 |
| Current P/E | 63.7 |
| YoY Growth | 29.5% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 18.0% to 9.6% (-8.4% in 5 days), indicating relative weakness vs NASDAQ. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 94th percentile. MRS_5 (-2.3%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 11.7% shows strong absolute momentum above own 20MA. Outperforming sector by 8.5pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.84), confirming momentum. RSI neutral at 58.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 9.63% (CS: 95) | Strong |
| RSI_14 | 58.2 | Neutral |
| MACD Histogram | 2.84 | Bullish |
| vs SMA20 | 1.117x | Above |
| vs SMA50 | 1.151x | Above |
| vs SMA200 | 1.774x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $178.94
- **Stop Loss:** $148.56 (17.0% risk)
- **Target:** $239.70 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 39
- **Position Value:** $6,978.66
- **Portfolio %:** 6.98%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-03-03 (Est: $0.79)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.50 | $0.67 | +35.3% |
| 2025Q3 | $0.36 | $0.52 | +44.2% |
| 2025Q2 | $0.27 | $0.35 | +27.9% |
| 2025Q1 | $0.18 | $0.25 | +36.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*